These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 6339045)
1. Cellular uptake and inhibition of DNA synthesis by dihydroxyanthraquinone and two analogues. Nishio A; Uyeki EM Cancer Res; 1983 May; 43(5):1951-6. PubMed ID: 6339045 [TBL] [Abstract][Full Text] [Related]
2. Comparative structure-genotoxicity study of three aminoanthraquinone drugs and doxorubicin. Au WW; Butler MA; Matney TS; Loo TL Cancer Res; 1981 Feb; 41(2):376-9. PubMed ID: 7448780 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of dihydroxyanthraquinone and adriamycin on the survival of cultured Chinese hamster cells. Kimler BF; Cheng CC Cancer Res; 1982 Sep; 42(9):3631-6. PubMed ID: 7105035 [TBL] [Abstract][Full Text] [Related]
4. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of DNA synthesis by chromium compounds. Nishio A; Uyeki EM J Toxicol Environ Health; 1985; 15(2):237-44. PubMed ID: 3892022 [TBL] [Abstract][Full Text] [Related]
6. Bis-substituted hydroxy-anthracenediones: DNA binding and biological activity. Palumbo M; Palù G; Gia O; Ferrazzi E; Gastaldi S; Antonello C; Meloni GA Anticancer Drug Des; 1987 Apr; 1(4):337-46. PubMed ID: 3450303 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of new anthraquinone derivatives. Ferrazzi E; Palumbo M; Valisena S; Antonello C; Palù G Chemioterapia; 1986 Oct; 5(5):330-6. PubMed ID: 3791481 [TBL] [Abstract][Full Text] [Related]
8. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling. Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204 [TBL] [Abstract][Full Text] [Related]
9. Effects of 9,10-anthracenedione, 1,4-bis[(2-[(2-hydroxyethyl)amino]-ethyl)amino]-diacetate on cell survival and cell cycle progression in cultured mammalian cells. Evenson DP; Darzynkiewicz Z; Staiano-Coico L; Traganos F; Melamed MR Cancer Res; 1979 Jul; 39(7 Pt 1):2574-81. PubMed ID: 286637 [No Abstract] [Full Text] [Related]
10. Relationship between cytotoxicity and DNA damage in mammalian cells treated with anthracenedione derivatives. Locher SE; Meyn RE Chem Biol Interact; 1983 Sep; 46(3):369-79. PubMed ID: 6357512 [TBL] [Abstract][Full Text] [Related]
11. Effects of 9,10-anthracenedione, 1,4-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-, diacetate on cell morphology and nucleic acids of friend leukemia cells. Evenson DP; Traganos F; Darzynkiewicz Z; Staiano-Coico L; Melamed MR J Natl Cancer Inst; 1980 Apr; 64(4):857-66. PubMed ID: 6928997 [TBL] [Abstract][Full Text] [Related]
12. Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives. Zagotto G; Sissi C; Moro S; Dal Ben D; Parkinson GN; Fox KR; Neidle S; Palumbo M Bioorg Med Chem; 2008 Jan; 16(1):354-61. PubMed ID: 17936629 [TBL] [Abstract][Full Text] [Related]
13. Effect of dihydroxyanthraquinone (DHAQ) and radiation on the survival of cultured Chinese hamster ovary cells. Kimler BF Radiat Res; 1983 Feb; 93(2):406-15. PubMed ID: 6681675 [TBL] [Abstract][Full Text] [Related]
14. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution. Lansiaux A; Tanious F; Mishal Z; Dassonneville L; Kumar A; Stephens CE; Hu Q; Wilson WD; Boykin DW; Bailly C Cancer Res; 2002 Dec; 62(24):7219-29. PubMed ID: 12499262 [TBL] [Abstract][Full Text] [Related]
15. Contamination is a frequent confounding factor in toxicology studies with anthraquinone and related compounds. Butterworth BE; Mathre OB; Ballinger KE; Adalsteinsson O Int J Toxicol; 2004; 23(5):335-44. PubMed ID: 15513832 [TBL] [Abstract][Full Text] [Related]
16. Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones. Zee-Cheng RK; Cheng CC J Med Chem; 1978 Mar; 21(3):291-4. PubMed ID: 628005 [TBL] [Abstract][Full Text] [Related]
17. Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis. Faaland CA; Thomas TJ; Balabhadrapathruni S; Langer T; Mian S; Shirahata A; Gallo MA; Thomas T Biochem Cell Biol; 2000; 78(4):415-26. PubMed ID: 11012080 [TBL] [Abstract][Full Text] [Related]
18. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541 [TBL] [Abstract][Full Text] [Related]
19. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity. Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890 [TBL] [Abstract][Full Text] [Related]
20. Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation. Rosowsky A; Vaidya CM; Bader H; Wright JE; Teicher BA J Med Chem; 1997 Jan; 40(3):286-99. PubMed ID: 9022795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]